Uipath, INC Form 4 insider transactions
NYSE
PATH
Uipath, INCUiPath CEO Daniel Dines reported the transfer of over 9.6 million Class A Common Stock shares due to a divorce settlement, retaining voting rights but relinquishing pecuniary interest.
NYSE
PATH
Uipath, INCUiPath's Chief Operating and Financial Officer, Ashim Gupta, reported the acquisition of 288,321 Class A Common Stock shares through the vesting of performance-based restricted stock units.
NYSE
PATH
Uipath, INCUiPath's General Counsel and Chief Legal Officer, Brad Brubaker, increased his beneficial ownership by 145,985 shares of Class A Common Stock through the earning of performance-based restricted stock units.
NYSE
PATH
Uipath, INCUiPath's Chief Accounting Officer, Hitesh Ramani, reported the vesting of 31,021 performance-based restricted stock units.
NYSE
PATH
Uipath, INCUiPath CEO Daniel Dines executed planned sales of Class A Common Stock totaling 135,000 shares over three days in late January 2026 under a Rule 10b5-1 plan.
NYSE
PATH
Uipath, INCUiPath CEO and Chairman Daniel Dines sold 45,000 shares of Class A Common Stock for an average price of $15.3753 per share under a pre-arranged 10b5-1 trading plan.
NYSE
PATH
Uipath, INCUiPath CEO Daniel Dines sold 45,000 shares of Class A Common Stock for approximately $15.68 per share under a pre-arranged Rule 10b5-1 trading plan.
NYSE
PATH
Uipath, INCUiPath CEO Daniel Dines sold 45,000 shares of Class A Common Stock for approximately $773,208 as part of a pre-arranged trading plan.
NYSE
PATH
Uipath, INCUiPath CEO Daniel Dines reported the sale of 45,000 Class A Common Stock shares at an average price of $16.6096, executed under a pre-arranged Rule 10b5-1 trading plan.
NYSE
PATH
Uipath, INCUiPath CEO Daniel Dines sold 45,000 shares of Class A Common Stock for approximately $17.17 per share on January 9, 2026, under a pre-arranged 10b5-1 trading plan.
NYSE
PATH
Uipath, INCUiPath CEO Daniel Dines sold 45,000 shares of Class A Common Stock on January 8, 2026, under a pre-arranged 10b5-1 trading plan.
NYSE
PATH
Uipath, INCUiPath CEO Daniel Dines sold 45,000 shares of Class A Common Stock for approximately $17.32 per share under a pre-arranged 10b5-1 trading plan.
NYSE
PATH
Uipath, INCUiPath's Chief Accounting Officer, Hitesh Ramani, had 24,968 shares withheld by the company to cover tax obligations related to RSU vesting.
NYSE
PATH
Uipath, INCUiPath's Chief Accounting Officer, Hitesh Ramani, filed an amended Form 4 to correct a clerical error in his reported beneficial ownership of Class A Common Stock.
NYSE
PATH
Uipath, INCUiPath's GC & Chief Legal Officer, Brad Brubaker, reported a disposition of 34,843 shares for tax obligations and an ESPP purchase.
NYSE
PATH
Uipath, INCUiPath's COO and CFO, Ashim Gupta, reported the sale of Class A Common Stock and shares withheld for tax obligations, reducing his direct beneficial ownership.
NYSE
PATH
Uipath, INCUiPath CEO Daniel Dines sold 45,000 shares of Class A Common Stock for an average price of $15.9937 per share under a pre-arranged 10b5-1 trading plan.
NYSE
PATH
Uipath, INCUiPath CEO and Chairman Daniel Dines sold 45,000 shares of Class A Common Stock for an average price of $15.7318 under a pre-arranged 10b5-1 trading plan.
NYSE
PATH
Uipath, INCUiPath CEO Daniel Dines sold 45,000 shares of Class A Common Stock for approximately $16.38 per share under a pre-arranged 10b5-1 trading plan.
NYSE
PATH
Uipath, INCUiPath CEO Daniel Dines sold 90,000 Class A Common Stock shares in late December 2025 through a pre-arranged 10b5-1 trading plan.
NYSE
PATH
Uipath, INCUiPath CEO Daniel Dines sold 135,000 shares of Class A Common Stock across three transactions in late December 2025, pursuant to a Rule 10b5-1 plan.
NYSE
PATH
Uipath, INCUiPath CEO Daniel Dines executed planned sales of 90,000 Class A Common Stock shares totaling approximately $1.48 million under a 10b5-1 plan.
NYSE
PATH
Uipath, INCUiPath CEO Daniel Dines filed an amended Form 4 to correct an inadvertent omission of 9.6 million Class A Common Stock shares held indirectly.
NYSE
PATH
Uipath, INCUiPath CEO Daniel Dines filed an amended Form 4 to correct an inadvertent omission of 9.6 million indirectly held shares.
NYSE
PATH
Uipath, INCUiPath CEO Daniel Dines sold 45,000 shares of Class A Common Stock for approximately $16.07 per share, executed under a pre-arranged 10b5-1 trading plan.
NYSE
PATH
Uipath, INCUiPath CEO Daniel Dines sold 45,000 Class A Common Stock shares for $730,156 under a pre-arranged 10b5-1 trading plan.
NYSE
PATH
Uipath, INCUiPath CEO Daniel Dines converted over 9.6 million Class B shares to Class A and subsequently sold 45,000 Class A shares under a pre-arranged plan.
NYSE
PATH
Uipath, INCUiPath CEO and Chairman Daniel Dines sold 45,000 shares of Class A Common Stock for approximately $731,515 on December 16, 2025, under a pre-arranged Rule 10b5-1 trading plan.
NYSE
PATH
Uipath, INCUiPath CEO and Chairman Daniel Dines sold a total of 90,000 Class A Common Stock shares in December 2025 under a pre-arranged 10b5-1 trading plan.
NYSE
PATH
Uipath, INCUiPath CEO Daniel Dines sold 45,000 shares of Class A Common Stock for an average price of $18.5612 on December 11, 2025, under a pre-arranged 10b5-1 plan.